Användare:EdytheMcCart

NEW YORK, Jan 18 (Reuters) - Gilead Sciences Inc said an unauthorized community of drug distributors and suppliers offered pharmacies more than $250 million of counterfeit versions of its HIV treatments over the last two years, endangering patients. The drugmaker stated it discovered 85,247 bottles that had been tampered with or Tefine faked, including versions of its Biktarvy and Descovy therapies. In a separate assertion on Wednesday, Gilead said it has seized the bottles of Gilead-labeled remedy from 17 locations in 9 states as part of its investigation. The investigation additionally uncovered unauthorized pharmaceutical distributors who had been selling the medication to pharmacies, Gilead said. Gilead stated on Tuesday counterfeiters used genuine, Tekfin however typically empty or generico Pulmeno near-empty, bottles that after contained its HIV treatment. It stated the counterfeiters then substituted pretend tablets and generic Flucoxan documentation, and resealed the bottles so they would "resemble" unopened, authentic bottles. The alleged scheme was reported earlier by The Wall Avenue Journal. Gilead disclosed its anti-counterfeiting efforts on the same day a federal choose in Brooklyn unsealed a related civil lawsuit that the Foster Metropolis, California-primarily based company filed last July. Gilead stated a standard counterfeit was an anti-psychotic drug that usually causes drowsiness, where tablets had been six times more potent than the U.S. Meals and Drug Administration recommended for some patients. It said one patient who unknowingly took that drug after receiving a pretend bottle of Biktarvy reported being unable to talk or walk afterwards. The lawsuit seeks, among other cures, the seizure of counterfeit drugs, along with court docket-ordered seizures which have already occurred. Global sales of its HIV remedies totaled $4.19 billion in the quarter ending Sept. 30, Nor%20vibrax generic 2021, together with $2.71 billion of Biktarvy and Descovy. Lori Mayall, Gilead's prime anti-counterfeiting government, said the presiding choose in its lawsuit ordered the defendant distributors to stop promoting Gilead-branded medications, and the company was unaware of any defendant violating that order. Mayall said in a statement. generico Pulmeno